Report Detail

Pharma & Healthcare Global Parenteral Formula Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

  • RnM4590129
  • |
  • 21 May, 2024
  • |
  • Global
  • |
  • 121 Pages
  • |
  • GIR (Global Info Research)
  • |
  • Pharma & Healthcare

Parenteral formulas are specialized liquid formulations administered intravenously to provide essential nutrients and fluids to individuals who are unable to obtain adequate nutrition through oral or enteral routes. Parenteral formulas are typically prescribed for patients with severe gastrointestinal disorders, malabsorption syndromes, or other medical conditions that impair their ability to absorb nutrients from food.
According to our (Global Info Research) latest study, the global Parenteral Formula market size was valued at US$ million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of %during review period.
This report is a detailed and comprehensive analysis for global Parenteral Formula market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global Parenteral Formula market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
Global Parenteral Formula market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
Global Parenteral Formula market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
Global Parenteral Formula market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Parenteral Formula
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Parenteral Formula market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Baxter International lnc., B.Braun Melsungen AG, Fresenius Kabi AG, Hospira, Inc., Sichuan Kelun Pharmaceutical Co.,Ltd., Otsuka Pharmaceutical Co.,Ltd., Grifols, S.A., Aculife Healthcare Private Limited, Vifor Pharma Group, Terumo Corporation, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Parenteral Formula market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Carbohydrates
Amino Acids
Lipids
Electrolytes
Vitamins and Minerals
Specialty Formulas
Market segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Major players covered
Baxter International lnc.
B.Braun Melsungen AG
Fresenius Kabi AG
Hospira, Inc.
Sichuan Kelun Pharmaceutical Co.,Ltd.
Otsuka Pharmaceutical Co.,Ltd.
Grifols, S.A.
Aculife Healthcare Private Limited
Vifor Pharma Group
Terumo Corporation
Nutricia
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Parenteral Formula product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Parenteral Formula, with price, sales quantity, revenue, and global market share of Parenteral Formula from 2019 to 2024.
Chapter 3, the Parenteral Formula competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Parenteral Formula breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Parenteral Formula market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Parenteral Formula.
Chapter 14 and 15, to describe Parenteral Formula sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Parenteral Formula Consumption Value by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Carbohydrates
    • 1.3.3 Amino Acids
    • 1.3.4 Lipids
    • 1.3.5 Electrolytes
    • 1.3.6 Vitamins and Minerals
    • 1.3.7 Specialty Formulas
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Parenteral Formula Consumption Value by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Hospital Pharmacies
    • 1.4.3 Retail Pharmacies
    • 1.4.4 Online Pharmacies
  • 1.5 Global Parenteral Formula Market Size & Forecast
    • 1.5.1 Global Parenteral Formula Consumption Value (2019 & 2023 & 2030)
    • 1.5.2 Global Parenteral Formula Sales Quantity (2019-2030)
    • 1.5.3 Global Parenteral Formula Average Price (2019-2030)

2 Manufacturers Profiles

  • 2.1 Baxter International lnc.
    • 2.1.1 Baxter International lnc. Details
    • 2.1.2 Baxter International lnc. Major Business
    • 2.1.3 Baxter International lnc. Parenteral Formula Product and Services
    • 2.1.4 Baxter International lnc. Parenteral Formula Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Baxter International lnc. Recent Developments/Updates
  • 2.2 B.Braun Melsungen AG
    • 2.2.1 B.Braun Melsungen AG Details
    • 2.2.2 B.Braun Melsungen AG Major Business
    • 2.2.3 B.Braun Melsungen AG Parenteral Formula Product and Services
    • 2.2.4 B.Braun Melsungen AG Parenteral Formula Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 B.Braun Melsungen AG Recent Developments/Updates
  • 2.3 Fresenius Kabi AG
    • 2.3.1 Fresenius Kabi AG Details
    • 2.3.2 Fresenius Kabi AG Major Business
    • 2.3.3 Fresenius Kabi AG Parenteral Formula Product and Services
    • 2.3.4 Fresenius Kabi AG Parenteral Formula Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Fresenius Kabi AG Recent Developments/Updates
  • 2.4 Hospira, Inc.
    • 2.4.1 Hospira, Inc. Details
    • 2.4.2 Hospira, Inc. Major Business
    • 2.4.3 Hospira, Inc. Parenteral Formula Product and Services
    • 2.4.4 Hospira, Inc. Parenteral Formula Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Hospira, Inc. Recent Developments/Updates
  • 2.5 Sichuan Kelun Pharmaceutical Co.,Ltd.
    • 2.5.1 Sichuan Kelun Pharmaceutical Co.,Ltd. Details
    • 2.5.2 Sichuan Kelun Pharmaceutical Co.,Ltd. Major Business
    • 2.5.3 Sichuan Kelun Pharmaceutical Co.,Ltd. Parenteral Formula Product and Services
    • 2.5.4 Sichuan Kelun Pharmaceutical Co.,Ltd. Parenteral Formula Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Sichuan Kelun Pharmaceutical Co.,Ltd. Recent Developments/Updates
  • 2.6 Otsuka Pharmaceutical Co.,Ltd.
    • 2.6.1 Otsuka Pharmaceutical Co.,Ltd. Details
    • 2.6.2 Otsuka Pharmaceutical Co.,Ltd. Major Business
    • 2.6.3 Otsuka Pharmaceutical Co.,Ltd. Parenteral Formula Product and Services
    • 2.6.4 Otsuka Pharmaceutical Co.,Ltd. Parenteral Formula Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Otsuka Pharmaceutical Co.,Ltd. Recent Developments/Updates
  • 2.7 Grifols, S.A.
    • 2.7.1 Grifols, S.A. Details
    • 2.7.2 Grifols, S.A. Major Business
    • 2.7.3 Grifols, S.A. Parenteral Formula Product and Services
    • 2.7.4 Grifols, S.A. Parenteral Formula Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Grifols, S.A. Recent Developments/Updates
  • 2.8 Aculife Healthcare Private Limited
    • 2.8.1 Aculife Healthcare Private Limited Details
    • 2.8.2 Aculife Healthcare Private Limited Major Business
    • 2.8.3 Aculife Healthcare Private Limited Parenteral Formula Product and Services
    • 2.8.4 Aculife Healthcare Private Limited Parenteral Formula Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Aculife Healthcare Private Limited Recent Developments/Updates
  • 2.9 Vifor Pharma Group
    • 2.9.1 Vifor Pharma Group Details
    • 2.9.2 Vifor Pharma Group Major Business
    • 2.9.3 Vifor Pharma Group Parenteral Formula Product and Services
    • 2.9.4 Vifor Pharma Group Parenteral Formula Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Vifor Pharma Group Recent Developments/Updates
  • 2.10 Terumo Corporation
    • 2.10.1 Terumo Corporation Details
    • 2.10.2 Terumo Corporation Major Business
    • 2.10.3 Terumo Corporation Parenteral Formula Product and Services
    • 2.10.4 Terumo Corporation Parenteral Formula Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 Terumo Corporation Recent Developments/Updates
  • 2.11 Nutricia
    • 2.11.1 Nutricia Details
    • 2.11.2 Nutricia Major Business
    • 2.11.3 Nutricia Parenteral Formula Product and Services
    • 2.11.4 Nutricia Parenteral Formula Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.11.5 Nutricia Recent Developments/Updates

3 Competitive Environment: Parenteral Formula by Manufacturer

  • 3.1 Global Parenteral Formula Sales Quantity by Manufacturer (2019-2024)
  • 3.2 Global Parenteral Formula Revenue by Manufacturer (2019-2024)
  • 3.3 Global Parenteral Formula Average Price by Manufacturer (2019-2024)
  • 3.4 Market Share Analysis (2023)
    • 3.4.1 Producer Shipments of Parenteral Formula by Manufacturer Revenue ($MM) and Market Share (%): 2023
    • 3.4.2 Top 3 Parenteral Formula Manufacturer Market Share in 2023
    • 3.4.3 Top 6 Parenteral Formula Manufacturer Market Share in 2023
  • 3.5 Parenteral Formula Market: Overall Company Footprint Analysis
    • 3.5.1 Parenteral Formula Market: Region Footprint
    • 3.5.2 Parenteral Formula Market: Company Product Type Footprint
    • 3.5.3 Parenteral Formula Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Parenteral Formula Market Size by Region
    • 4.1.1 Global Parenteral Formula Sales Quantity by Region (2019-2030)
    • 4.1.2 Global Parenteral Formula Consumption Value by Region (2019-2030)
    • 4.1.3 Global Parenteral Formula Average Price by Region (2019-2030)
  • 4.2 North America Parenteral Formula Consumption Value (2019-2030)
  • 4.3 Europe Parenteral Formula Consumption Value (2019-2030)
  • 4.4 Asia-Pacific Parenteral Formula Consumption Value (2019-2030)
  • 4.5 South America Parenteral Formula Consumption Value (2019-2030)
  • 4.6 Middle East & Africa Parenteral Formula Consumption Value (2019-2030)

5 Market Segment by Type

  • 5.1 Global Parenteral Formula Sales Quantity by Type (2019-2030)
  • 5.2 Global Parenteral Formula Consumption Value by Type (2019-2030)
  • 5.3 Global Parenteral Formula Average Price by Type (2019-2030)

6 Market Segment by Application

  • 6.1 Global Parenteral Formula Sales Quantity by Application (2019-2030)
  • 6.2 Global Parenteral Formula Consumption Value by Application (2019-2030)
  • 6.3 Global Parenteral Formula Average Price by Application (2019-2030)

7 North America

  • 7.1 North America Parenteral Formula Sales Quantity by Type (2019-2030)
  • 7.2 North America Parenteral Formula Sales Quantity by Application (2019-2030)
  • 7.3 North America Parenteral Formula Market Size by Country
    • 7.3.1 North America Parenteral Formula Sales Quantity by Country (2019-2030)
    • 7.3.2 North America Parenteral Formula Consumption Value by Country (2019-2030)
    • 7.3.3 United States Market Size and Forecast (2019-2030)
    • 7.3.4 Canada Market Size and Forecast (2019-2030)
    • 7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe

  • 8.1 Europe Parenteral Formula Sales Quantity by Type (2019-2030)
  • 8.2 Europe Parenteral Formula Sales Quantity by Application (2019-2030)
  • 8.3 Europe Parenteral Formula Market Size by Country
    • 8.3.1 Europe Parenteral Formula Sales Quantity by Country (2019-2030)
    • 8.3.2 Europe Parenteral Formula Consumption Value by Country (2019-2030)
    • 8.3.3 Germany Market Size and Forecast (2019-2030)
    • 8.3.4 France Market Size and Forecast (2019-2030)
    • 8.3.5 United Kingdom Market Size and Forecast (2019-2030)
    • 8.3.6 Russia Market Size and Forecast (2019-2030)
    • 8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific

  • 9.1 Asia-Pacific Parenteral Formula Sales Quantity by Type (2019-2030)
  • 9.2 Asia-Pacific Parenteral Formula Sales Quantity by Application (2019-2030)
  • 9.3 Asia-Pacific Parenteral Formula Market Size by Region
    • 9.3.1 Asia-Pacific Parenteral Formula Sales Quantity by Region (2019-2030)
    • 9.3.2 Asia-Pacific Parenteral Formula Consumption Value by Region (2019-2030)
    • 9.3.3 China Market Size and Forecast (2019-2030)
    • 9.3.4 Japan Market Size and Forecast (2019-2030)
    • 9.3.5 South Korea Market Size and Forecast (2019-2030)
    • 9.3.6 India Market Size and Forecast (2019-2030)
    • 9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
    • 9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America

  • 10.1 South America Parenteral Formula Sales Quantity by Type (2019-2030)
  • 10.2 South America Parenteral Formula Sales Quantity by Application (2019-2030)
  • 10.3 South America Parenteral Formula Market Size by Country
    • 10.3.1 South America Parenteral Formula Sales Quantity by Country (2019-2030)
    • 10.3.2 South America Parenteral Formula Consumption Value by Country (2019-2030)
    • 10.3.3 Brazil Market Size and Forecast (2019-2030)
    • 10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa

  • 11.1 Middle East & Africa Parenteral Formula Sales Quantity by Type (2019-2030)
  • 11.2 Middle East & Africa Parenteral Formula Sales Quantity by Application (2019-2030)
  • 11.3 Middle East & Africa Parenteral Formula Market Size by Country
    • 11.3.1 Middle East & Africa Parenteral Formula Sales Quantity by Country (2019-2030)
    • 11.3.2 Middle East & Africa Parenteral Formula Consumption Value by Country (2019-2030)
    • 11.3.3 Turkey Market Size and Forecast (2019-2030)
    • 11.3.4 Egypt Market Size and Forecast (2019-2030)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
    • 11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics

  • 12.1 Parenteral Formula Market Drivers
  • 12.2 Parenteral Formula Market Restraints
  • 12.3 Parenteral Formula Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Parenteral Formula and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Parenteral Formula
  • 13.3 Parenteral Formula Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Parenteral Formula Typical Distributors
  • 14.3 Parenteral Formula Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Parenteral Formula. Industry analysis & Market Report on Parenteral Formula is a syndicated market report, published as Global Parenteral Formula Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of Parenteral Formula market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,742.24
    4,113.36
    5,484.48
    3,250.32
    4,875.48
    6,500.64
    547,473.60
    821,210.40
    1,094,947.20
    290,788.80
    436,183.20
    581,577.60
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report